文献速递脊柱关节炎

男性和女性中轴型脊柱关节炎患者达到非活动性疾病状态:多国前瞻性观察性研究结果

Achieving inactive disease state in men and women with axial spondyloarthritis: results from a multi-country prospective observational study.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

该研究为PROOF研究的1年事后分析,纳入1385例新诊断(≤12个月)的中轴型脊柱关节炎(axSpA)患者,比较男女患者达到低疾病活动度(LDA)和非活动性疾病(ID)的概率。结果显示,在非放射学axSpA(nr-axSpA)中,男性达到LDA和ID的比例显著高于女性,而在放射学axSpA(r-axSpA)中无显著差异。作者认为,女性nr-axSpA患者较男性更不易达到LDA和ID。

要点

  • nr-axSpA男性达到ASDAS LDA的比例为46.0%,女性为27.1%(P=0.0002)。
  • nr-axSpA男性达到ID的比例为21.7%,女性为9.6%(P=0.0013)。
  • r-axSpA中男女达到LDA和ID无显著差异。

核心结论

  • 女性nr-axSpA患者(而非r-axSpA患者)在1年后达到LDA和ID的可能性低于男性。
  • 这些数据强调需要仔细评估诊断为axSpA患者的诊断和疼痛原因。

研究设计与样本

  • PROOF研究是一项多国前瞻性观察性研究,本分析为其1年事后分析。
  • 纳入新诊断(≤12个月)axSpA患者,通过中心放射学判读分为放射学(r)或非放射学(nr)axSpA。
  • 共纳入1385例有基线和第1年数据的患者,其中nr-axSpA 477例(34%;男性47%),r-axSpA 908例(66%;男性71%)。
  • 在基线和之后每年评估人口学、疾病特征和治疗,第1年采用ASDAS评估疾病活动度。

主要发现

  • 基线时,nr-axSpA男性TNF抑制剂使用率高于女性(15% vs 9%;P=0.0238),r-axSpA男性亦高于女性(20% vs 13%;P=0.0118)。
  • 第1年时TNF抑制剂使用增加,r-axSpA男性仍显著高于女性(34.9% vs 28.1%;P=0.0497),nr-axSpA中无显著差异。
  • nr-axSpA男性达到ASDAS LDA的比例显著高于女性(46.0% vs 27.1%;P=0.0002),达到ID的比例亦显著高于女性(21.7% vs 9.6%;P=0.0013)。
  • r-axSpA中男女达到LDA和ID无显著差异。
  • 仅在nr-axSpA中,女性性别与达到LDA和ID的 odds 显著降低相关(男性 vs 女性,LDA:OR 2.23 [95% CI 1.45, 3.42];ID:OR 2.40 [95% CI 1.39, 4.12])。

关键数值与推荐

  • nr-axSpA男性 vs 女性达到ASDAS LDA:46.0% vs 27.1%(P=0.0002)。
  • nr-axSpA男性 vs 女性达到ID:21.7% vs 9.6%(P=0.0013)。
  • nr-axSpA男性 vs 女性达到LDA的OR为2.23(95% CI 1.45, 3.42),达到ID的OR为2.40(95% CI 1.39, 4.12)。
  • r-axSpA第1年TNF抑制剂使用:男性34.9% vs 女性28.1%(P=0.0497)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the probability of achieving low disease activity (LDA) and inactive disease (ID) in men vs women with recently diagnosed axial spondyloarthritis (axSpA). METHODS: This 1-year post-hoc analysis of the PROOF study assessed patients with recently diagnosed (≤12 months) axSpA. Patients were classified as having radiographic (r) or non-radiographic (nr) axSpA using central radiograph readings. Demographics, disease characteristics, and treatment were assessed at baseline and annually thereafter. Disease activity at 1 year was assessed by Axial Spondyloarthritis Disease Activity Score (ASDAS). RESULTS: 1385 patients with baseline and year 1 data were included. Patients were classified as having nr-axSpA (n = 477 [34%]; 47% men) or r-axSpA (n = 908 [66%]; 71% men). Men had higher TNF inhibitor (TNFi) use vs women with nr-axSpA (15% vs 9%; P = 0.0238) and r-axSpA (20% vs 13%; P = 0.0118). At 1 year, TNFi use increased, remaining significantly higher for men with r-axSpA (34.9% vs 28.1%; P = 0.0497) but not nr-axSpA. Significantly more men with nr-axSpA achieved ASDAS LDA (46.0% vs 27.1%; P = 0.0002) and ID (21.7% vs 9.6%; P = 0.0013); no significant difference was observed in r-axSpA. Female sex was associated with significantly lower odds of achieving LDA and ID in nr-axSpA only (odds ratio, men vs women, LDA: 2.23 [95% CI, 1.45, 3.42]; ID: 2.40 [1.39, 4.12]). CONCLUSION: Women with nr-axSpA, but not r-axSpA, were less likely to achieve LDA and ID after 1 year than men. These data stress the need to carefully evaluate the diagnosis and causes of pain in patients diagnosed with axSpA.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Poddubnyy D, Sieper J, Akar S, et al. Achieving inactive disease state in men and women with axial spondyloarthritis: results from a multi-country prospective observational study. Rheumatology (Oxford). 2025. PMID: 40833778. doi:10.1093/rheumatology/keaf447

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。